| For: | Altlparmak E, Köklü S, Yallnklllc M, Yüksel O, Cicek B, Kayacetin E, Sahin T. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol 2005; 11(20): 3056-3059 [PMID: 15918189 DOI: 10.3748/wjg.v11.i20.3056] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3056.htm |
| Number | Citing Articles |
| 1 |
Mohammad Minakari, Mahsa Molaei, Hamid Mohaghegh Shalmani, Amir Houshang Mohammad Alizadeh, Amir Hosein Davarpanah Jazi, Nosratollah Naderi, Ahmad Shavakhi, Reza Mashayekhi, Mohammad Reza Zali. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. European Journal of Gastroenterology & Hepatology 2009; 21(5) doi: 10.1097/MEG.0b013e328326792e
|
| 2 |
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liver. Orvosi Hetilap 2015; 156(14) doi: 10.1556/OH.2015.30123
|
| 3 |
Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal. Hepatitis B and End-Stage Liver Disease. Clinics in Liver Disease 2007; 11(4) doi: 10.1016/j.cld.2007.08.009
|
| 4 |
Jun‐ping Shi, Jian‐gao Fan, Rui Wu, Xiao‐qian Gao, Li Zhang, Hao Wang, Geoffrey C Farrell. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. Journal of Gastroenterology and Hepatology 2008; 23(9) doi: 10.1111/j.1440-1746.2008.05531.x
|
| 5 |
Yu-Qiang Mi, Qi-Yu Shi, Liang Xu, Rui-Fang Shi, Yong-Gang Liu, Ping Li, Feng Shen, Wei Lu, Jian-Gao Fan. Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B. Digestive Diseases and Sciences 2015; 60(1) doi: 10.1007/s10620-014-3341-x
|
| 6 |
Waseem AL-dulaimy, Khalid Sahab, Joodi Al-Janab Al-Janab, Mohammed Kadhom, Baraa Abdulhadi. INTELECTIN-1 AS A DIAGNOSTIC BIOMARKER FOR NONALCOHOLIC FATTY LIVER DISEASE. BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY 2025; doi: 10.58240/1829006X-2025.21.5-100
|
| 7 |
Manoj Kumar, Ajay Choudhury, Nitin Manglik, Syed Hissar, Archana Rastogi, Puja Sakhuja, Shiv K Sarin. Insulin Resistance in Chronic Hepatitis B Virus Infection. The American Journal of Gastroenterology 2009; 104(1) doi: 10.1038/ajg.2008.9
|
| 8 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2) doi: 10.1111/apt.15575
|
| 9 |
Reham M. Gameaa, Nehad Hawash, Rehab Badawi, Sherief Abd-Elsalam, Gamal K. Kasem, El-Sayed A. Wasfy. Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance. The Open Biomarkers Journal 2019; 9(1) doi: 10.2174/1875318301909010070
|
| 10 |
Rosa Zampino, Nicola Coppola, Grazia Cirillo, Adriana Boemio, Anna Grandone, Maria Stanzione, Nicolina Capoluongo, Aldo Marrone, Margherita Macera, Evangelista Sagnelli, Luigi Elio Adinolfi, Emanuele Miraglia del Giudice. Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B. Digestive Diseases and Sciences 2015; 60(10) doi: 10.1007/s10620-015-3716-7
|
| 11 |
Shruti Kare, Asmita Hamand. KNOWLEDGE, ATTITUDE AND PRACTICE OF GENERIC MEDICINES AMONG DENTAL GRADUATES AND POSTGRADUATE STUDENTS OF NORTH MAHARASHTRA REGION.. BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY 2025; doi: 10.58240/1829006X-2025.21.4-323
|
| 12 |
E. Tsochatzis, G.V. Papatheodoridis, E.K. Manesis, N. Chrysanthos, G. Kafiri, A.J. Archimandritis. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: A comparative approach with genotype 1 chronic hepatitis C. Digestive and Liver Disease 2007; 39(10) doi: 10.1016/j.dld.2007.07.151
|
| 13 |
Alice Emma Taliento, Marcello Dallio, Alessandro Federico, Daniele Prati, Luca Valenti. Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease. International Journal of Environmental Research and Public Health 2019; 16(15) doi: 10.3390/ijerph16152755
|
| 14 |
Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Winnie Chiu-Wing Chu, Angel Mei-Ling Chim, Arlinking Ong, David Ka-Wai Yeung, Karen Kar-Lum Yiu, Shirley Ho-Ting Chu, Hoi-Yun Chan, Jean Woo, Francis Ka-Leung Chan, Henry Lik-Yuen Chan. Hepatitis B virus infection and fatty liver in the general population. Journal of Hepatology 2012; 56(3) doi: 10.1016/j.jhep.2011.09.013
|
| 15 |
Mauro Viganò, Luca Valenti, Pietro Lampertico, Floriana Facchetti, Benedetta Maria Motta, Roberta D'Ambrosio, Solange Romagnoli, Paola Dongiovanni, Benedetta Donati, Silvia Fargion, Massimo Colombo. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Hepatology 2013; 58(4) doi: 10.1002/hep.26445
|
| 16 |
Angélica Luciana Nau, Júlia Cristina Soares, Maria Beatriz Cacese Shiozawa, Esther Buzaglo Dantas-Corrêa, Leonardo de Lucca Schiavon, Janaína Luz Narciso-Schiavon. Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(2) doi: 10.1590/0037-8682-0009-2014
|
| 17 |
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease. Human Vaccines & Immunotherapeutics 2017; 13(11) doi: 10.1080/21645515.2017.1353850
|
| 18 |
Chia‐Chi Wang, Tai‐Chung Tseng, Jia‐Horng Kao. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?. Journal of Gastroenterology and Hepatology 2015; 30(1) doi: 10.1111/jgh.12700
|
| 19 |
Jing Liang, Wenjuan Cai, Tao Han, Li Jing, Zhe Ma, Yingtang Gao. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease. Medicine 2016; 95(52) doi: 10.1097/MD.0000000000005763
|
| 20 |
Shao-Wen Wang, Yu-Wen Chang, Ching Wang, Yu-Ming Cheng, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng Kao. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World Journal of Hepatology 2024; 16(12): 1429-1440 doi: 10.4254/wjh.v16.i12.1429
|
| 21 |
Mariana V Machado, António G Oliveira, Helena Cortez‐Pinto. Hepatic steatosis in hepatitis B virus infected patients: Meta‐analysis of risk factors and comparison with hepatitis C infected patients. Journal of Gastroenterology and Hepatology 2011; 26(9) doi: 10.1111/j.1440-1746.2011.06801.x
|
| 22 |
Mehmet Cindoruk, Tarkan Karakan, Selahattin Unal. Hepatic Steatosis has no Impact on the Outcome of Treatment in Patients With Chronic Hepatitis B Infection. Journal of Clinical Gastroenterology 2007; 41(5) doi: 10.1097/01.mcg.0000225586.78330.60
|
| 23 |
Xudong Liu, Zhen Shen, Hongxing Zhang, Jian Liang, Hai Lin. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease. Journal of Interferon & Cytokine Research 2016; 36(6) doi: 10.1089/jir.2015.0129
|
| 24 |
Dandan Peng, Ying Han, Huiguo Ding, Lai Wei. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. Journal of Gastroenterology and Hepatology 2008; 23(7pt1) doi: 10.1111/j.1440-1746.2008.05478.x
|
| 25 |
Ya-Yu Wang, Shih-Yi Lin, Wayne Huey-Herng Sheu, Pi-Hwa Liu, Kwong-Chung Tung. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism 2010; 59(4) doi: 10.1016/j.metabol.2009.07.038
|
| 26 |
Chieh Liu, Yi-Fen Shih, Chun-Jen Liu. Treatment strategies for patients with hepatitis B virus infection coexisting with hepatitis C virus or metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology 2026; 32(2) doi: 10.3350/cmh.2025.1227
|
| 27 |
Ranj Hama, Mohammed Mohammed, Mohsin Mohammed. ROLE OF THE FIBROSCAN IN ASSESSING CHRONIC LIVER DISEASES. JOURNAL OF SULAIMANI MEDICAL COLLEGE 2022; 12(4) doi: 10.17656/jsmc.10375
|
| 28 |
|
| 29 |
Yi-Cheng Chen, Chao-Wei Hsu, Wen-Juei Jeng, Chun-Yen Lin. Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients. Digestive Diseases and Sciences 2021; 66(12) doi: 10.1007/s10620-020-06761-x
|
| 30 |
Arezoo Estakhri, Ali Akbari Sari, Sahar Naz Nedjat, Marym Rohban, Naser Rakhshani, Seyed Mohammad Tavangar, Reza Malekzadeh, Ghodrat Montazeri. The effect of NAFLD (non-alcoholic fatty liver disease) on long-term outcome of chronic hepatitis B in Iranian patients. Open Journal of Gastroenterology 2012; 2(01) doi: 10.4236/ojgas.2012.21004
|
| 31 |
Abdol Sattar Pagheh, Effat Alemzadeh, Eisa Nazar, Mitra Moodi, Farshad Sharifi, Ebrahim Miri-Moghaddam, Mohamad Taghi Rahimi, Soroush Mohammadi, Masood Ziaee. Monitoring of hepatitis B infection in the elderly population of eastern Iran. Vacunas 2025; 26(1) doi: 10.1016/j.vacun.2024.08.002
|
| 32 |
Chu-wen Lin, Xiao-li Huang, Hai-lin Liu, Yan Wang. Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. Digestive Diseases and Sciences 2015; 60(12) doi: 10.1007/s10620-015-3772-z
|
| 33 |
Konstantinos C. Thomopoulos, Vassiliki Arvaniti, Athanasios C. Tsamantas, Dimitra Dimitropoulou, Charalambos A. Gogos, Dimitrios Siagris, George J. Theocharis, Chryssoula Labropoulou-Karatza. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. European Journal of Gastroenterology & Hepatology 2006; 18(3) doi: 10.1097/00042737-200603000-00002
|
| 34 |
Abdol Sattar Pagheh, Effat Alemzadeh, Eisa Nazar, Mitra Moodi, Farshad Sharifi, Ebrahim Miri-Moghaddam, Mohamad Taghi Rahimi, Soroush Mohammadi, Masood Ziaee. Monitoring of hepatitis B infection in the elderly population of eastern Iran. Vacunas (English Edition) 2025; 26(1) doi: 10.1016/j.vacune.2025.100373
|
| 35 |
Zhan-Ming Li, Chao-Yue Kong, Shi-Long Zhang, Bing Han, Zheng-Yan Zhang, Li-Shun Wang. Alcohol and HBV synergistically promote hepatic steatosis. Annals of Hepatology 2019; 18(6) doi: 10.1016/j.aohep.2019.04.013
|
| 36 |
Erin M. Kelly, Vickie A. Feldstein, Dustin Etheridge, Rebecca Hudock, Marion G. Peters. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B. Journal of Ultrasound in Medicine 2017; 36(5) doi: 10.7863/ultra.16.04076
|
| 37 |
Lu Wang, Chang Lu, Yuncong Zhang, Qingsheng Liang, Jie Zhang. Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-023-03103-9
|
| 38 |
Mohsen Razavizade, Raika Jamali, Abbas Arj, Hamidreza Talari. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2012; 11(5) doi: 10.1016/S1499-3872(12)60216-1
|
| 39 |
Wei-Chieh Hung, Jin-Shang Wu, Zih-Jie Sun, Feng-Hwa Lu, Yi-Ching Yang, Chih-Jen Chang. Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population. BMJ Open 2016; 6(11) doi: 10.1136/bmjopen-2016-013106
|
| 40 |
Ming Yang, Lai Wei. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia. Liver International 2022; 42(9) doi: 10.1111/liv.15252
|
| 41 |
Daisuke Yamane, David R. McGivern, Takahiro Masaki, Stanley M. Lemon. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Current Topics in Microbiology and Immunology 2013; 369 doi: 10.1007/978-3-642-27340-7_11
|
| 42 |
Suraphan Panyod, Lee-Yan Sheen. Beneficial effects of Chinese herbs in the treatment of fatty liver diseases. Journal of Traditional and Complementary Medicine 2020; 10(3) doi: 10.1016/j.jtcme.2020.02.008
|
| 43 |
Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, Mengting Li, Yuanwen Chen, Jun Li, Jiangao Fan. Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?. Liver International 2020; 40(3) doi: 10.1111/liv.14369
|
| 44 |
Li-chen Wu, Ja-an Annie Ho. Spirulina in Human Nutrition and Health. 2007; doi: 10.1201/9781420052572.ch6
|
| 45 |
KyeongJin Kim, Kook Hwan Kim, Hyeong Hoe Kim, JaeHun Cheong. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRα. Biochemical Journal 2008; 416(2) doi: 10.1042/BJ20081336
|
| 46 |
Qi Zheng, Biyao Zou, Yuankai Wu, Yeehui Yeo, Huizhen Wu, Christopher D Stave, Ramsey C. Cheung, Mindie H. Nguyen. Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2021; 54(9) doi: 10.1111/apt.16595
|
| 47 |
Wei‐Chieh Hung, Jin‐Shang Wu, Yi‐Ching Yang, Zih‐Jie Sun, Feng‐Hwa Lu, Chih‐Jen Chang. Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis. European Journal of Clinical Investigation 2014; 44(12) doi: 10.1111/eci.12348
|
| 48 |
Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2020; 35(11) doi: 10.1111/jgh.15026
|
| 49 |
Kouamé Hatrydt Guillaume Dimitri, Kissi Anzouan-Kacou Henriette Ya, Gogan Patricia, Bangoura Aboubacar Demba, Doffou Stanislas Adjeka, Mahassadi Kouame Alassan, Yao Bathaix Fulgence Mamert, Attia Alain Koffi. Factors Associated with Hepatic Steatosis in Black African Subjects with Chronic Viral Hepatitis B in Côte d’Ivoire. Open Journal of Gastroenterology 2023; 13(10) doi: 10.4236/ojgas.2023.1310030
|
| 50 |
Jin Tong, Jinjun Guo, Jun Hu, Sihui Hou, Yu Zhang, Qingling Li. Correlation Between Patatin-Like Phospholipase Domain-Containing Protein 3 Gene Polymorphisms and Liver Cirrhosis in a Chinese Han Population With Chronic Hepatitis B. Hepatitis Monthly 2014; 14(8) doi: 10.5812/hepatmon.18943
|
| 51 |
Salvatore Petta, Calogero Cammà, Vito Di Marco, Fabio Salvatore Macaluso, Marcello Maida, Giuseppe Pizzolanti, Beatrice Belmonte, Daniela Cabibi, Rosa Di Stefano, Donatella Ferraro, Carla Guarnotta, Giovanna Venezia, Antonio Craxì. Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver International 2011; 31(4) doi: 10.1111/j.1478-3231.2011.02453.x
|
| 52 |
Ghodsiyeh Azarkar, Tayebeh Zeinali, Gholamreza Sharifzadeh, Farshid Abedi, Morteza Hajihosseini, Masood Ziaee. Prevalence of Non-Alcoholic Fatty Liver and its Related Factors in Birjand, During Year 2015. Modern Care Journal 2016; 13(4) doi: 10.5812/modernc.58829
|
| 53 |
Anthony W.H. Chan, Grace L.H. Wong, Vincent W.S. Wong. Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B Infection. Current Hepatology Reports 2017; 16(2) doi: 10.1007/s11901-017-0340-3
|
| 54 |
Zhengtao Liu, Yanling Hu, Xiaobo Yang, Aihua Tan, Yong Gao, Xue Qin, Yu Liang, Zengnan Mo, Tao Peng. Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern China. Clinical Biochemistry 2012; 45(18) doi: 10.1016/j.clinbiochem.2012.08.022
|
| 55 |
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events. Middle East Journal of Digestive Diseases 2020; 12(2) doi: 10.34172/mejdd.2020.166
|
| 56 |
Vahdat Poortahmasebi, Seyed Moayed Alavian, Hossein Keyvani, Mehdi Norouzi, Mahmood Mahmoodi, Seyed Mohammad Jazayeri. Hepatic Steatosis: Prevalence and Host/Viral Risk Factors in Iranian Patients with Chronic Hepatitis B Infection. Asian Pacific Journal of Cancer Prevention 2014; 15(9) doi: 10.7314/APJCP.2014.15.9.3879
|
| 57 |
G. Forlani, P. Di Bonito, E. Mannucci, B. Capaldo, S. Genovese, M. Orrasch, L. Scaldaferri, P. Di Bartolo, P. Melandri, A. Dei Cas, I. Zavaroni, G. Marchesini. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. Journal of Endocrinological Investigation 2008; 31(2) doi: 10.1007/BF03345581
|
| 58 |
Jian‐Gao Fan, Shivakumar Chitturi. Hepatitis B and fatty liver: Causal or coincidental?. Journal of Gastroenterology and Hepatology 2008; 23(5) doi: 10.1111/j.1440-1746.2008.05361.x
|
| 59 |
Xi Jin, Yi-peng Chen, Yi-da Yang, You-ming Li, Lin Zheng, Chuan-qing Xu, Ravi Jhaveri. Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B. PLoS ONE 2012; 7(3) doi: 10.1371/journal.pone.0034198
|
| 60 |
Huiqing Liang, Yaoyu Liu, Xiaoqian Jiang, Xiaoting Zheng, Jinmo Tang, Jiaen Yang, Hongli Zhuang, Penghua Lai, Li Peng, Zhenying Guo, Shanshan Cai, Dan Luo, Lingxia Xu, Qianguo Mao, Shaodong Chen. Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism. Gastroenterology Research and Practice 2020; 2020 doi: 10.1155/2020/1794769
|
| 61 |
Zehra Karacaer, Gokcan Okur, Hakan Cermik, Demet Altun. Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?. Postgraduate Medicine 2016; 128(7) doi: 10.1080/00325481.2016.1221733
|
| 62 |
Zixuan Wang, Qingyang Xu, Mengyu Wang, Qianqian Xiao, Yanhuang Xu, Xiaoying Wang, Yiwen Shi, Ruixu Yang, Jian-Gao Fan. Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients and Mice with Wilson Disease. The American Journal of Pathology 2025; 195(9) doi: 10.1016/j.ajpath.2025.05.009
|
| 63 |
Raphael B. Merriman. Nonalcoholic fatty liver disease and HIV infection. Current HIV/AIDS Reports 2006; 3(3) doi: 10.1007/BF02696654
|
| 64 |
Mostafa Mohamed El-Sheekh, Saied Mohamed Hamad, Mahmoud Gomaa. Protective effects of Spirulina on the liver function and hyperlipidemia of rats and human. Brazilian Archives of Biology and Technology 2014; 57(1) doi: 10.1590/S1516-89132014000100012
|
| 65 |
C-M Chu, D-Y Lin, Y-F Liaw. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?. International Journal of Obesity 2007; 31(5) doi: 10.1038/sj.ijo.0803479
|
| 66 |
Silvia Bondini, Jillian Kallman, Angela Wheeler, Shivaani Prakash, Terry Gramlich, Daniel M. Jondle, Zobair M. Younossi. Impact of non‐alcoholic fatty liver disease on chronic hepatitis B. Liver International 2007; 27(5) doi: 10.1111/j.1478-3231.2007.01482.x
|
| 67 |
Joseph K. Lim, Mindie H. Nguyen. The Role of Hepatic Steatosis in Chronic Hepatitis B Infection. Current Hepatitis Reports 2011; 10(2) doi: 10.1007/s11901-011-0090-6
|
| 68 |
Saman Ghalamkari, Heidar Sharafi, Seyed Moayed Alavian. Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: Systematic review with meta‐analysis. The Journal of Gene Medicine 2018; 20(1) doi: 10.1002/jgm.3001
|
| 69 |
Yi-Fen Shih, Chieh Liu, Chun-Jen Liu. Comprehensive Guide to Hepatitis Advances. 2023; doi: 10.1016/B978-0-323-98368-6.00020-3
|
| 70 |
Raluca Pais, Elena Rusu, Vlad Ratziu. The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis B and Drug-Induced Liver Disease. Clinics in Liver Disease 2014; 18(1) doi: 10.1016/j.cld.2013.09.015
|